We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.62%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$112B
AUM Growth
+$936M
(+0.84%)
Cap. Flow
-$1.26B
Cap. Flow
% of AUM
-1.13%
Top 10 Holdings %
Top 10 Hldgs %
31.26%
Holding
4,289
New
46
Increased
1,994
Reduced
1,731
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXE
Expand Energy Corp
EXE
|
+$56.7M |
| 2 |
Apollo Global Management
APO
|
+$36.8M |
| 3 |
Boeing
BA
|
+$34.1M |
| 4 |
Workday
WDAY
|
+$31.9M |
| 5 |
DOCU
DocuSign
DOCU
|
+$26.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$136M |
| 2 |
NVIDIA
NVDA
|
+$110M |
| 3 |
Microsoft
MSFT
|
+$84.1M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$48.4M |
| 5 |
XYZ
Block Inc
XYZ
|
+$44.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.97% |
| 2 | Financials | 13.53% |
| 3 | Consumer Discretionary | 11.77% |
| 4 | Healthcare | 10.06% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Celldex Therapeutics
CLDX
$3.28B
| $2.32M | ﹤0.01% |
91,939
-650
| -0.7% | -$17.7K |
|
1802
ANI Pharmaceuticals
ANIP
$1.78B
| $2.32M | ﹤0.01% |
42,007
-203
| -0.5% | -$11.7K |
|
1803
CEVA Inc
CEVA
$1.08B
| $2.31M | ﹤0.01% |
73,270
+2,027
| +3% | +$56.4K |
|
|
TRST
1804
Trustco Bank Corp NY
TRST
$938M
| $2.3M | ﹤0.01% |
69,175
-22
| -0% | -$765 |
|
1805
Monarch Casino & Resort
MCRI
$2.23B
| $2.3M | ﹤0.01% |
29,203
-117
| -0.4% | -$9.44K |
|
|
UMH
1806
UMH Properties
UMH
$1.36B
| $2.29M | ﹤0.01% |
121,417
+11,471
| +10% | +$219K |
|
1807
Compass Diversified
CODI
$828M
| $2.29M | ﹤0.01% |
99,298
-891
| -0.9% | -$20K |
|
1808
Koppers
KOP
$969M
| $2.29M | ﹤0.01% |
70,685
+574
| +0.8% | +$20.5K |
|
|
AVNS
1809
DELISTED
Avanos Medical
AVNS
| $2.29M | ﹤0.01% |
143,843
-2,016
| -1% | -$39.9K |
|
1810
Monro
MNRO
$398M
| $2.29M | ﹤0.01% |
92,195
-3,941
| -4% | -$108K |
|
1811
Madison Square Garden
MSGE
$3.62B
| $2.28M | ﹤0.01% |
64,162
-971
| -1% | -$37.5K |
|
|
ODP
1812
DELISTED
ODP
ODP
| $2.28M | ﹤0.01% |
100,414
-9,865
| -9% | -$275K |
|
|
SHOE
1813
Shoe Station Group
SHOE
$428M
| $2.28M | ﹤0.01% |
69,001
+12,445
| +22% | +$451K |
|
1814
Kforce
KFRC
$1.06B
| $2.27M | ﹤0.01% |
40,093
+1,425
| +4% | +$82.8K |
|
1815
SSR Mining
SSRM
$6.48B
| $2.27M | ﹤0.01% |
325,929
+3,681
| +1% | +$22.9K |
|
|
REVG
1816
DELISTED
REV Group
REVG
| $2.27M | ﹤0.01% |
71,130
+1,000
| +1% | +$29.7K |
|
1817
Capitol Federal Financial
CFFN
$1.1B
| $2.27M | ﹤0.01% |
383,530
-2,722
| -0.7% | -$17.4K |
|
1818
Seaboard Corp
SEB
$4.06B
| $2.26M | ﹤0.01% |
931
+8
| +0.9% | +$22K |
|
1819
Helios Technologies
HLIO
$2.76B
| $2.26M | ﹤0.01% |
50,612
+726
| +1% | +$35.9K |
|
1820
Tecnoglass Holdings Inc.
TGLS
$1.96B
| $2.26M | ﹤0.01% |
28,474
-564
| -2% | -$42.9K |
|
1821
Recursion Pharmaceuticals
RXRX
$1.73B
| $2.26M | ﹤0.01% |
334,032
+23,564
| +8% | +$158K |
|
1822
Forward Air
FWRD
$654M
| $2.25M | ﹤0.01% |
69,879
-113
| -0.2% | -$3.94K |
|
|
HEES
1823
DELISTED
H&E Equipment Services
HEES
| $2.24M | ﹤0.01% |
45,678
+745
| +2% | +$40.6K |
|
1824
Summit Therapeutics
SMMT
$11.1B
| $2.23M | ﹤0.01% |
125,202
+5,394
| +5% | +$105K |
|
1825
Weis Markets
WMK
$1.86B
| $2.23M | ﹤0.01% |
32,934
+109
| +0.3% | +$7.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2024 Portfolio in Review
As of Q4 2024, RhumbLine Advisers held 4,289 positions worth $112B, up 0.84% from $111B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 2.8%. RhumbLine Advisers opened 46 new positions and exited 73, leaving the 4,289-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q4 2024 buy was Expand Energy Corp: 614,703 shares worth $61.2M.
- RhumbLine Advisers added most to Apollo Global Management in Q4 2024, an estimated $36.8M increase.
- RhumbLine Advisers's biggest Q4 2024 reduction was Apple, cutting an estimated $136M.
- RhumbLine Advisers fully exited Block Inc in Q4 2024, selling an estimated $44.9M.
- RhumbLine Advisers's ten largest holdings make up 31% of its $112B portfolio in Q4 2024.
- RhumbLine Advisers opened 46 new positions and closed 73 in Q4 2024.
- RhumbLine Advisers's portfolio value rose 0.84% quarter-over-quarter to $112B.
Based on RhumbLine Advisers's 13F filing for Q4 2024, filed 30 Jan 2025.